Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma
Authors
Keywords
-
Journal
Oncogenesis
Volume 9, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-14
DOI
10.1038/s41389-020-0207-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UHRF1 is regulated by miR‐124‐3p and promotes cell proliferation in intrahepatic cholangiocarcinoma
- (2019) Mengxuan Zhu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma
- (2017) Hao Li et al. HEPATOLOGY
- Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport
- (2017) Arvindhan Nagarajan et al. MOLECULAR CELL
- Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
- (2016) Han Zhang et al. CANCER LETTERS
- A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
- (2016) Sumera Rizvi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Mir-148a in Cancer
- (2016) Yue Li et al. Journal of Cancer
- YAP is a critical oncogene in human cholangiocarcinoma
- (2015) Tiemin Pei et al. Oncotarget
- Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells
- (2015) Andreas Koch et al. Oncotarget
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- The Warburg effect: molecular aspects and therapeutic possibilities
- (2014) Hanh Ngo et al. MOLECULAR BIOLOGY REPORTS
- Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
- (2013) Tiziano Tuccinardi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer
- (2013) A. Zabron et al. Disease Models & Mechanisms
- Changing pattern of epidemiology in intrahepatic cholangiocarcinoma
- (2013) Basile Njei HEPATOLOGY
- Serglycin Is a Theranostic Target in Nasopharyngeal Carcinoma that Promotes Metastasis
- (2011) X.-J. Li et al. CANCER RESEARCH
- GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker
- (2011) Kátia C. Carvalho et al. Clinics
- AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma
- (2010) Olivier Farges et al. CANCER
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
- (2009) Michael P Kim et al. Nature Protocols
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma
- (2008) Lei Chen et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started